Verition Fund Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,500
Closed -$1M 3872
2025
Q3
$1M Sell
7,500
-1,000
-12% -$121K ﹤0.01% 2537
2025
Q2
$1.06M Sell
8,500
-700
-8% -$89.1K ﹤0.01% 2431
2025
Q1
$1.17M Hold
9,200
0.01% 2007
2024
Q4
$1.32M Buy
+9,200
New +$1.32M 0.01% 1850

Other funds holding RGEN

Verition Fund Management's RGEN Position: Q4 2025 in Review

Verition Fund Management sold out of Repligen (RGEN) in Q4 2025, closing a stake of 13,186 shares — an estimated $1.76M sold.

Verition Fund Management first reported a position in RGEN in Q3 2016 and held it in 16 quarters. The position peaked at $1.76M in Q3 2025. 474 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

  • Verition Fund Management reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 13,186 Repligen shares in Q4 2025, an estimated $1.76M.
  • Verition Fund Management first reported a position in Repligen in Q3 2016 and held it in 16 quarters.
  • Verition Fund Management's Repligen position peaked at $1.76M in Q3 2025.
  • 474 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.